GTGenrich V. Tolstonog

Genrich V. Tolstonog

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Genrich V. Tolstonog has a total of 38 co-authors. Here are the top co-authors by number of shared publications:

  • Wolfgang Deppert

    Heinrich-Pette-Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany

    6 shared publications
  • Gabriele Warnecke

    Heinrich-Pette-Institute; Leibniz Institute for Experimental Virology; Hamburg; Germany

    2 shared publications
  • Alexander Kirilyuk

    Vologda City Hospital No. 1

    1 shared publication
  • Annette Damert

    Max-Planck-Institut für Zellbiologie, Rosenhof, D-68526 Ladenburg and 2Paul-Ehrlich-Institut, Section PR2/Retroelements, Paul-Ehrlich-Strasse 51-59, D-63225 Langen, Germany

    1 shared publication
  • Annette März

    Heinrich-Pette-Institute; Leibniz Institute for Experimental Virology; Hamburg; Germany

    1 shared publication
  • Axel V. Horn

    Max-Planck-Institut für Zellbiologie, Rosenhof, D-68526 Ladenburg and 2Paul-Ehrlich-Institut, Section PR2/Retroelements, Paul-Ehrlich-Strasse 51-59, D-63225 Langen, Germany

    1 shared publication

Latest Publications

  • Open Access

    Mutant p53 is a transcriptional co-factor that binds to G-rich regulatory regions of active genes and generates transcriptional plasticity

    by Timo Quante, Benjamin Otto, Marie Brázdová, Iva Kejnovská, Wolfgang Deppert, Genrich V. Tolstonog

    The molecular mechanisms underlying mutant p53 (mutp53) “gain-of-function” (GOF) are still insufficiently understood, but there is evidence that mutp53 is a transcriptional regulator that is recruited by specialized transcription factors. Here we analyzed the binding sites of mutp53 and the epigenetic status of mutp53-regulated genes that had been identified by global expression profiling upon depletion of endogenous mutp53 (R273H) expression in U251 glioblastoma cells. We found that mutp53 preferentially and autonomously binds to G/C-rich DNA around transcription start sites (TSS) of many genes characterized by active chromatin marks (H3K4me3) and frequently associated with transcription-competent RNA polymerase II. Mutp53-bound regions overlap predominantly with CpG islands and are enriched in G4-motifs that are prone to form G-quadruplex structures. In line, mutp53 binds and stabilizes a well-characterized G-quadruplex structure in vitro. Hence, we assume that binding of mutp53 to G/C-rich DNA regions associated with a large set of cancer-relevant genes is an initial step in their regulation by mutp53. Using GAS1 and HTR2A as model genes, we show that mutp53 affects several parameters of active transcription. Finally, we discuss a dual mode model of mutp53 GOF, which includes both stochastic and deterministic components.


  • Recombinant p53 displays heterogeneity during isoelectric focusing

    by Jochen Heukeshoven, Annette März, Gabriele Warnecke, Wolfgang Deppert, Genrich V. Tolstonog


  • p53 Models for Mammary Carcinogenesis

    by Wolfgang Deppert, Genrich Tolstonog

  • Open Access

    Tumorigenic WAP-T Mouse Mammary Carcinoma Cells: A Model for a Self-Reproducing Homeostatic Cancer Cell System

    by Florian Wegwitz, Mark-Andreas Kluth, Claudia Mänz, Benjamin Otto, Katharina Gruner, Christina Heinlein, Marion Kühl, Gabriele Warnecke, Udo Schumacher, Wolfgang Deppert, et al.

    In analogy to normal stem cell differentiation, the current cancer stem cell (CSC) model presumes a hierarchical organization and an irreversible differentiation in tumor tissue. Accordingly, CSCs should comprise only a small subset of the tumor cells, which feeds tumor growth. However, some recent findings raised doubts on the general applicability of the CSC model and asked for its refinement. In this study we analyzed the CSC properties of mammary carcinoma cells derived from transgenic (WAP-T) mice. We established a highly tumorigenic WAP-T cell line (G-2 cells) that displays stem-like traits. G-2 cells, as well as their clonal derivates, are closely related to primary tumors regarding histology and gene expression profiles, and reflect heterogeneity regarding their differentiation states. G-2 cultures comprise cell populations in distinct differentiation states identified by co-expression of cytoskeletal proteins (cytokeratins and vimentin), a combination of cell surface markers and a set of transcription factors. Cellular subsets sorted according to expression of CD24a, CD49f, CD61, Epcam, Sca1, and Thy1 cell surface proteins, or metabolic markers (e.g. ALDH activity) are competent to reconstitute the initial cellular composition. Repopulation efficiency greatly varies between individual subsets and is influenced by interactions with the respective complementary G-2 cellular subset. The balance between differentiation states is regulated in part by the transcription factor Sox10, as depletion of Sox10 led to up-regulation of Twist2 and increased the proportion of Thy1-expressing cells representing cells in a self-renewable, reversible, quasi-mesenchymal differentiation state. G-2 cells constitute a self-reproducing cancer cell system, maintained by bi- and unidirectional conversion of complementary cellular subsets. Our work contributes to the current controversial discussion on the existence and nature of CSC and provides a basis for the incorporation of alternative hypotheses into the CSC model.


  • Metabolic sensing by p53: Keeping the balance between life and death

    by Genrich V. Tolstonog, Wolfgang Deppert

    There is no life without stress, and there is no life without mechanisms for adaptation to stress. Stress perturbs the balance of a living system, thereby scrutinizing the plasticity of its regulatory networks. These networks shape the composition and behavior of living systems. Biological networks serve the adaptability of the whole system, wherein multiple sensors and effectors cooperate to achieve maximal efficiency. Such interlacing cooperation needs to be controlled in relays (effectors) that integrate incoming signals and direct outgoing signals. The list of such powerful cellular effectors is short. In multicellular organisms, proteins of the p53 family (1) are well-studied examples of such effectors; as transcriptional factors, they balance the regulation of cell fate between proliferation, differentiation, and death. p53 is a relatively short-lived protein whose stability is regulated by multiple counteracting mechanisms targeting p53 to, or preventing it from, ubiquitin-dependent (2) or -independent (3) proteasomal degradation. The article by Khutornenko et al. (4) in PNAS reports a surprising connection between p53 stabilization (activation) in cancer cells and mitochondrial function. The mitochondrion is a versatile enzymatic engine that senses the metabolic requirements of cells and utilizes biochemical pathways in accordance with the cells’ proliferative or differentiation status or with a normal or transformed state. Regulation of mitochondrial activity in transformed cells also requires adaptation to changing aerobic and anaerobic conditions depending on energy supply through blood vessels and metabolic symbiosis in tumor cells (5). Because many metabolic pathways intersect in mitochondria, and because some of them directly rely on electron flow through the electron transport chain (ETC) (e.g., de novo pyrimidine synthesis), the communication between this organelle and the cell nucleus is essential. The cross-talk between these organelles has been best studied in yeast. During retrograde response (RTG) (6), for example, three proteins, Rtg2 (sensor) and Rtg1/Rtg3 (transcription factor heterocomplex), …


  • Open Access

    Modulation of gene expression in U251 glioblastoma cells by binding of mutant p53 R273H to intronic and intergenic sequences

    by Marie Brázdová, Timo Quante, Lars Tögel, Korden Walter, Christine Loscher, Vlastimil Tichý, Lenka Činčárová, Wolfgang Deppert, Genrich V. Tolstonog

    Missense point mutations in the TP53 gene are frequent genetic alterations in human tumor tissue and cell lines derived thereof. Mutant p53 (mutp53) proteins have lost sequence-specific DNA binding, but have retained the ability to interact in a structure-selective manner with non-B DNA and to act as regulators of transcription. To identify functional binding sites of mutp53, we established a small library of genomic sequences bound by p53 R273H in U251 human glioblastoma cells using chromatin immunoprecipitation (ChIP). Mutp53 binding to isolated DNA fragments confirmed the specificity of the ChIP. The mutp53 bound DNA sequences are rich in repetitive DNA elements, which are dispersed over non-coding DNA regions. Stable down-regulation of mutp53 expression strongly suggested that mutp53 binding to genomic DNA is functional. We identified the PPARGC1A and FRMD5 genes as p53 R273H targets regulated by binding to intronic and intra-genic sequences. We propose a model that attributes the oncogenic functions of mutp53 to its ability to interact with intronic and intergenic non-B DNA sequences and modulate gene transcription via re-organization of chromatin.


  • Open Access

    Functional endogenous LINE-1 retrotransposons are expressed and mobilized in rat chloroleukemia cells

    by Alexander Kirilyuk, Genrich V. Tolstonog, Annette Damert, Ulrike Held, Silvia Hahn, Roswitha Löwer, Christian Buschmann, Axel V. Horn, Peter Traub, Gerald G. Schumann

    LINE-1 (L1) is a highly successful autonomous non-LTR retrotransposon and a major force shaping mammalian genomes. Although there are about 600 000 L1 copies covering 23% of the rat genome, full-length rat L1s (L1Rn) with intact open reading frames (ORFs) representing functional master copies for retrotransposition have not been identified yet. In conjunction with studies to elucidate the role of L1 retrotransposons in tumorigenesis, we isolated and characterized 10 different cDNAs from transcribed full-length L1Rn elements in rat chloroleukemia (RCL) cells, each encoding intact ORF1 proteins (ORF1p). We identified the first functional L1Rn retrotransposon from this pool of cDNAs, determined its activity in HeLa cells and in the RCL cell line the cDNAs originated from and demonstrate that it is mobilized in the tumor cell line in which it is expressed. Furthermore, we generated monoclonal antibodies directed against L1Rn ORF1 and ORF2-encoded recombinant proteins, analyzed the expression of L1-encoded proteins and found ORF1p predominantly in the nucleus. Our results support the hypothesis that the reported explosive amplification of genomic L1Rn sequences after their transcriptional activation in RCL cells is based on L1 retrotransposition. Therefore, L1 activity might be one cause for genomic instability observed during the progression of leukemia.


  • Spontaneously Immortalized Mouse Embryo Fibroblasts: Growth Behavior of Wild-Type and Vimentin-Deficient Cells in Relation to Mitochondrial Structure and Activity

    by Genrich V. Tolstonog, Irina V. Belichenko-Weitzmann, Jian-Ping Lu, Roland Hartig, Robert L. Shoeman, Ulrike Taub, Peter Traub

    Dependent on the presence or absence of vimentin, primary mouse embryo fibroblasts exhibit different growth characteristics in vitro. While most Vim+/+ fibroblasts stop dividing and die via apoptosis, a substantial fraction of cells immortalize and proliferate almost normally. Vim−/− fibroblasts cease to divide earlier, immortalize in vanishingly small numbers and thereafter proliferate extremely slowly. Early after immortalization, Vim+/+ imm fibroblasts appear structurally almost normal, whereas Vim−/− imm fibroblasts equal postmitotic "crisis" cells, which are characterized by increased cell size, altered cell ultrastructure, nuclear enlargement, genome destabilization, structural degeneration of mitochondria, and diminution of mitochondrial respiratory activity. The differences between immortalized Vim+/+ imm and Vim−/− imm fibroblasts persist during early cell cloning but disappear during serial subcultivation. At high cell passage, cloned, immortalized vim− fibroblasts grow nearly as fast as their cloned vim+ counterparts, and also resemble them in size, ultrastructure, nuclear volume, and mitochondrial complement; they very likely employ redundancy to cope with the loss of vimentin function when adjusting structure and behavior to that of immortalized vim+ fibroblasts. Reduction in nuclear size occurs via release of large amounts of filamentous chromatin into extracellular space; because it is complexed with extracellular matrix proteins, it tends to form clusters and to tightly stick to the surface of other cells, thus providing a potential for horizontal gene transfer. On the other hand, cloned vim+ and vim− fibroblasts are equal in showing contact inhibition at young age and becoming anchorage-independent during serial subcultivation, as indicated by the formation of multilayered and -faceted cell sheets and huge spheroids on top of or in soft agar. With this, immortalized vim− fibroblasts reduce their adhesiveness to the substratum which, in their precrisis state and early after cloning, is much higher than that of their vim+ counterparts. In addition, the coupling between the mitochondrial respiratory chain and oxidative phosphorylation is stronger in vim+ than vim− fibroblasts. It appears from these data that after explantation of fibroblasts from the mouse embryo the primary cause of cell and mitochondrial degeneration, including genomic instability, is the mitochondrial production of reactive oxygen species in a vicious circle, and that vimentin provides partial protection from oxidative damage. As a matrix protein with specific in vitro and in vivo affinities for nuclear and mitochondrial, recombinogenic DNA, it may exert this effect preferentially at the genome level via its influence on recombination and repair processes, and in this way also assist the cells in immortalizing. Additional protection of mitochondria by vimentin may occur at the level of mitochondrial fatty acid metabolism.